Impact of Comorbid Irritable Bowel Syndrome on Treatment Outcome in Non-Erosive Reflux Disease on Long-Term Proton Pump Inhibitor in Japan

Publisher： Karger

E-ISSN： 1421-9867|96|1|39-45

ISSN： 0012-2823

Source： Digestion, Vol.96, Iss.1, 2017-06, pp. : 39-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Reflections on Proton Pump Inhibitor Therapy for Non-Erosive Reflux Disease

By  

Digestion, Vol. 78, Iss. 1, 2008-10 ,pp. : 61-69

Karger

Access to resources Recommend Favorite

Is There a Unifying Role for Visceral Hypersensitivity and Irritable Bowel Syndrome in Non-Erosive Reflux Disease?

By  

Digestion, Vol. 78, Iss. 1, 2008-10 ,pp. : 42-45

Karger

Access to resources Recommend Favorite

Characteristics of Symptomatic Reflux Episodes in Patients with Non-Erosive Reflux Disease Who Have a Positive Symptom Index on Proton Pump Inhibitor Therapy

By  

Digestion, Vol. 82, Iss. 3, 2010-06 ,pp. : 156-161

Karger

Access to resources Recommend Favorite

Pathogenesis of Double-Dose Proton Pump Inhibitor-Resistant Non-Erosive Reflux Disease, and Mechanism of Reflux Symptoms and Gastric Acid Secretion-Suppressive Effect in the Presence or Absence of Helicobacter pylori Infection

By  

Digestion, Vol. 95, Iss. 2, 2017-02 ,pp. : 140-145

Karger

Access to resources Recommend Favorite

Patient Selection for Therapy Reduction after Long-Term Daily Proton Pump Inhibitor Treatment for Gastro-Oesophageal Reflux Disease: Trial and Error

By  

Digestion, Vol. 87, Iss. 2, 2013-01 ,pp. : 85-90

Karger

Access to resources Recommend Favorite